Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:FTV
NYSE:FTVMachinery

Fortive (NYSE:FTV) Reaffirms Q2 2025 Earnings Guidance of US$0.44-US$0.49 EPS

Fortive (NYSE:FTV) recently reaffirmed its earnings guidance for the second quarter of 2025, expecting diluted net earnings per share between $0.44 and $0.49. This stable outlook may have provided some support to their shares, which rose by 4% over the past week. This movement occurred amid broader market gains, aligning with the overall uptrend. As the market climbed 1.5% with anticipation around U.S.-China trade talks and corporate earnings, Fortive's performance seems to have echoed this...
BATS:CBOE
BATS:CBOECapital Markets

Cboe Global Markets (BATS:CBOE) Consolidates Digital Futures On CFE For Unified Trading Experience

Cboe Global Markets (BATS:CBOE) recently announced significant advancements, including the consolidation of its digital exchange futures onto the Cboe Futures Exchange and the introduction of Bitcoin and Ether futures on CFE. This move aims to enhance operational efficiencies and customer access, underpinning its leadership in volatility trading. Over the last quarter, Cboe's stock rose 4%, congruent with overall market trends buoyed by optimism surrounding U.S.-China trade talks...
ASX:MSB
ASX:MSBBiotechs

Mesoblast (ASX:MSB) Gains 15% In One Week With US FDA Orphan-Drug Approval

Mesoblast (ASX:MSB) experienced a 15% increase in its share price over the past week, largely driven by a significant orphan-drug approval by the U.S. FDA for Ryoncil. This approval, granting seven years of exclusivity for a vital treatment, likely bolstered investor confidence given the strengthened competitive positioning of Mesoblast. While broader market trends saw the S&P 500 and Nasdaq reach new highs amid positive investor sentiment on U.S.-China trade discussions, Mesoblast's specific...
NYSE:AWK
NYSE:AWKWater Utilities

American Water Works Company (NYSE:AWK) Welcomes Raffiq Nathoo To Its Board Of Directors

American Water Works Company (NYSE:AWK) recently appointed Raffiq Nathoo as an independent board member, enhancing its governance capabilities with his extensive experience in energy and investment management. While the stock price saw a 2% decline over the last week, the broader market experienced a 1.5% increase, buoyed by positive investor sentiment surrounding U.S.-China trade talks. The executive appointment may have added stability to the company amid these fluctuations but did not...
NYSE:KSS
NYSE:KSSMultiline Retail

Kohl's (NYSE:KSS) Sees 34% Price Jump Over Last Month

Kohl's (NYSE:KSS) recently completed a $360 million senior secured note offering, with proceeds earmarked to repay existing borrowings, highlighting a focus on strategic debt management amid ongoing financial adjustments. This, along with the first-quarter earnings report, showing a narrowed net loss despite a drop in sales and revenue, could have contributed to positive market sentiment. Against a backdrop of general market gains, such as the S&P 500 rising to its highest since February,...
TSX:OLA
TSX:OLAMetals and Mining

TSX Value Stocks That May Be Trading Below Their Worth June 2025

As the Canadian market navigates a landscape marked by trade developments and central bank meetings, investors are keenly watching for signs of volatility amid ongoing fiscal debates. Despite these challenges, the underlying fundamentals remain solid, providing a steady foundation for those seeking value opportunities in equities. In this context, identifying undervalued stocks can be particularly rewarding as they may offer potential upside when market conditions stabilize or improve.